Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laserscope (NASDAQ LSCP) -- Ignore unavailable to you. Want to Upgrade?

To: Dick Martin who wrote (275)	2/15/2000 4:50:00 AM
From: John Finley	Read Replies (1) \| Respond to of 314

Hello Dick Thanks for the link. Very informative! Having recently lost my Mother-In-Law, Sally, to lung cancer, any help would be a good thing. In fact I bought LSCP while doing research into alternate methods of treatment for her. Unfortunately PDT wasn't offered here and radiation was the only palliative (if you could call it that) treatment she received. I would bet that the new Varian emitter that they treated her with cost a little more than $150k. I do know a little about excimer lasers having used one for Pulsed Laser Deposition (PLD) for a number of years. Lambda Physik/Coherent (COHR) is the 300 lb. gorilla in the R&D market having bought out most of their competitors (hmmmm). Cymer (CYMI) came to talk to us about our application to see if they wanted to branch out but I think they stayed with photolithography <gg>. COHR might be the MSFT of lasers as they are aggressive and buy what they don't have. They list PDT on their website so it hasn't snuck up on them. I don't know how far along they are with PDT and this article about LSCP being in the Stanford University Medical Center is wonderful news for us. OT rant - I don't own any MO, etc. and wouldn't even if I knew it would rocket to the moon. My Father-In-Law had a similar fate as Sally and my mother has been addicted since she was 18. JF